4.2 Article

Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice

期刊

PROSTAGLANDINS & OTHER LIPID MEDIATORS
卷 104, 期 -, 页码 67-73

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.prostaglandins.2012.09.003

关键词

CYP2J2; Soluble epoxide hydrolase; Cyclooxygenase; Vascular inflammation; Epoxyeicosatrienoic acid; Prostaglandin

资金

  1. University of North Carolina at Chapel Hill Royster Society of Fellows Chancellor's Fellowship
  2. American Heart Association [T32 HL069768]
  3. American Foundation for Pharmaceutical Education
  4. Intramural Research Program of the NIH/NIEHS [Z01 ES050167, Z01 ES025034]
  5. [R01 GM088199]
  6. [R01 GM088199-S1]

向作者/读者索取更多资源

Cyclooxygenase (COX)-derived prostaglandins and cytochrome P450 (CYP) epoxygenase-derived epoxyeicosatrienoic acids are important regulators of inflammation; however, functional interactions' between these pathways in the regulation of vascular inflammation in vivo have not been studied. We investigated the relative and additive effects of endothelial CYP2J2 overexpression (Tie2-CYP2J2-Tr), global sEH disruption (Ephx2(-/-)), and pharmacologic COX inhibition with indomethacin on the acute vascular inflammatory response to endotoxin in mice. Compared to vehicle-treated wild-type C57BL/6 controls, induction of myeloperoxidase (MPO) activity in lung and liver was similarly attenuated in Tie2-CYP2J2-Tr mice, Ephx2(-/-) mice and wild-type mice treated with moderate dose indomethacin. Dual modulation of both pathways, however, did not produce an additive anti-inflammatory effect. These findings demonstrate that both COX and CYP epoxygenase-mediated eicosanoid metabolism are important regulators of the acute vascular inflammatory response in vivo, and suggest that the anti-inflammatory effects of modulating each pathway may be mediated, at least in part, by overlapping mechanisms. (C) 2012 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据